A New Rabbit Model of Chronic Dry Eye Disease Induced by Complete Surgical Dacryoadenectomy

Robert Honkanen1, Wei Huang1,2, Liqun Huang3,4

  • 1a Department of Ophthalmology, Health Sciences Center L2 , NY , USA.

Current Eye Research
|April 16, 2019
PubMed

Insights

A new rabbit model for dry eye disease (DED) was developed using surgical removal of lacrimal glands. This chronic DED model effectively mimics human disease, aiding in the study of ocular surface health and new drug development.

Area of Science:

  • Ophthalmology
  • Veterinary Medicine
  • Pharmacology

Background:

  • Dry eye disease (DED) is prevalent and inadequately treated, necessitating improved animal models for research.
  • Existing rabbit models for DED have limitations, including mild disease induction, inconsistency, and off-target effects from chemical agents.

Purpose of the Study:

  • To develop a novel, chronic rabbit model of DED that overcomes the limitations of current models.
  • To create a reproducible and severe DED model for studying disease mechanisms and therapeutic interventions.

Main Methods:

  • Surgical resection of all orbital lacrimal glands (dacryoadenectomy) in New Zealand White rabbits.
  • Sequential removal of orbital superior, palpebral superior, and inferior lacrimal glands under anesthesia.
  • Evaluation of DED parameters including tear break-up time, Schirmer tear test, tear osmolarity, and rose bengal staining.

Main Results:

  • Dacryoadenectomy induced severe, chronic aqueous-deficient DED, sustained for eight weeks.
  • Significant reductions in tear break-up time (>90%) and Schirmer tear test (50%) were observed.
  • Increased tear osmolarity (10%) and marked rose bengal staining confirmed disease severity.

Conclusions:

  • This surgical dacryoadenectomy model provides a stable, chronic, aqueous-deficient DED in rabbits.
  • The model accurately reflects key clinical and histological features of human DED.
  • It is suitable for investigating ocular surface homeostasis, DED pathophysiology, and evaluating DED drug efficacy.

Related Concept Videos

Chronic Obstructive Pulmonary Disease01:22

Chronic Obstructive Pulmonary Disease

COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
2.4K
Chronic Kidney Disease I: Introduction01:25

Chronic Kidney Disease I: Introduction

Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
620
Chronic Obstructive Pulmonary Disease-I: Introduction01:20

Chronic Obstructive Pulmonary Disease-I: Introduction

Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
3.6K
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
3.1K
Chronic Kidney Disease II: Clinical Manifestations01:24

Chronic Kidney Disease II: Clinical Manifestations

Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
607
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
4.3K